| HOME >> MEDICINE >> TECHNOLOGY |
corresponding Graph/Chart) 92
Table 39: Leading Players in Japanese Drug-Eluting Stent
Market (2010) - Percentage Breakdown of Share for Johnson &
Johnson and Boston Scientific (includes corresponding
Graph/Chart) 92
B.Market Analytics 93
Table 40: Japanese Recent Past, Current & Future Analysis
for Coronary Stents by Product Segment - Bare Metal and Drug
Eluting Stent Markets Independently Analyzed with Annual
Sales in US$ Million for years 2009 through 2017 (includes
corresponding Graph/Chart) 93
Table 41: Japanese Recent Past, Current & Future Analysis
for Coronary Stents by Product Segment - Bare Metal and Drug
Eluting Stent Markets Independently Analyzed with Annual
Sales in Thousand Units for years 2009 through 2017
(includes corresponding Graph/Chart) 94
Table 42: Japanese Historic Review for Coronary Stents by
Product Segment - Bare Metal and Drug Eluting Stent Markets
Independently Analyzed with Annual Sales in US$ Million for
years 2003 through 2008 (includes corresponding Graph/Chart) 95
Table 43: Japanese Historic Review for Coronary Stents by
Product Segment - Bare Metal and Drug Eluting Stent Markets
Independently Analyzed with Annual Sales in Thousand Units
for years 2003 through 2008 (includes corresponding
Graph/Chart) 96
Table 44: Japanese 15-Year Perspective for Coronary Stents
by Product Segment - Percentage Breakdown of Dollar Sales
for Bare Metal Stents and Drug Eluting Stents Markets for
years 2003, 2010 & 2017 (includes corresponding Graph/Chart) 97
Table 45: Japanese 15-Year Perspective for Coronary Stents
by Product Segment - Percentage Breakdown of Unit Sales for
Bare Metal Stents and Drug Eluting Stents Markets for years
2003, 2010 & 2017 (includes corresponding Gra
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |